XML 31 R18.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Stockholders Equity
6 Months Ended
Jun. 30, 2024
Stockholders Equity  
Stockholders' Equity

10. Stockholders’ Equity

 

Common Stock

 

The Company is authorized to issue 30,000,000 shares of common stock, $0.001 par value per share. As of June 30, 2024, there were 9,485,508 shares issued and outstanding.

 

During the three month period ended June 30, 2024, there were 189,155 shares of common stock vested in accordance with the vesting terms of restricted stock awards (RSAs). Three employees received less than the shares vested because they elected to have a total of 15,408 shares withheld in satisfaction of the employees corresponding tax liability of approximately $39,800. The Company’s payment of this tax liability was recorded as a cash flow from financing activity on the consolidated statement of cash flows.

 

During the six month period ended June 30, 2024, there were 692,468 shares of common stock vested in accordance with the vesting terms of RSAs. Nine employees received less than the shares vested because they elected to have a total of 100,180 shares withheld in satisfaction of the employees corresponding tax liability of approximately $258,400. The Company’s payment of this tax liability was recorded as a cash flow from financing activity on the consolidated statement of cash flows.

 

During the three month period June 30, 2023, there were 153,903 shares of common stock vested in accordance with the vesting terms of the RSAs. During the six month period ended June 30, 2023, there were 169,737 shares of common stock vested in accordance with the vesting terms of the RSAs. Two employees received less than the shares vested because they elected to have a total of 1,993 shares withheld in satisfaction of the employees corresponding tax liability of approximately $3,600. The Company’s payment of this tax liability was recorded as a cash flow from financing activity on the consolidated statement of cash flows.

 

There were no stock option exercises during the three and six month periods ended June 30, 2024 and 2023.

 

Contingent Warrants

 

Liability-classified warrants consist of warrants to acquire common stock at an exercise price of $5.33 per share as part of the consideration for the acquisition of ITA in 2021, during the earn-out period from 2021 to 2024. Based on our consideration of the ASC 815-40 guidance, we account for these contingent warrants as a liability. The estimated fair value of outstanding contingent warrants accounted for as liabilities is determined at each balance sheet date. Any decrease or increase in the estimated fair value of the warrant liability since the most recent balance sheet date is recorded in the consolidated statement of operations as other income (expense).  

Warrants Issued

 

On March 31, 2022, the Company issued a warrant to purchase 75,000 shares of common stock as part of the contingent consideration earned by ITA for 2021 EBITDA achievement. The warrant contains a strike price of $5.33 and has a four-year contractual term.